-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Abivax, Lowers Price Target to $135

Benzinga·06/02/2026 16:23:49
Listen to the news
Truist Securities analyst Gregory Renza maintains Abivax (NASDAQ:ABVX) with a Buy and lowers the price target from $140 to $135.